BRETT SHARP: Open Payments
NPI 1750301529 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 75 payments from 17 companies in 2025. Trend: 2023 $1,386 · 2024 $1,391 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $189 |
| Teva Pharmaceuticals USA, Inc. | 12 | $182 |
| Axsome Therapeutics, Inc. | 7 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $124 |
| Janssen Pharmaceuticals, Inc | 6 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $107 |
| Lundbeck LLC | 4 | $86 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Corium, LLC | 2 | $39 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, Auvelity, TRINTELLIX, FANAPT, REXULTI, SPRAVATO.
Industry payments across UT — which companies pay providers there.
